1-2 of 2
Carmela Anna Maria Tomaselli, MD
Close
Sort by
Journal Articles

A Population-Based Study of Chronic Myeloid Leukemia Treated with Imatinib in First Line

Fausto Castagnetti, MD, Francesco Di Raimondo, Antonio de Vivo, Antonio Spitaleri, Gabriele Gugliotta, Francesco Fabbiano, MD, Isabella Capodanno, Donato Mannina, MD, Marzia Salvucci, Agostino Antolino, Roberto Marasca, MD, Maurizio Musso, Monica Crugnola, MD, Stefana Impera, MD, Elena Trabacchi, Caterina Musolino, MD, Francesco Cavazzini, Giuseppe Mineo, Patrizia Tosi, Carmela Anna Maria Tomaselli, MD, Michele Rizzo, MD, Sergio Siragusa, MD, Miriam Fogli, Riccardo Ragionieri, Alessandro Zironi, Simona Soverini, Giovanni Martinelli, MD, Michele Cavo, Paolo Vigneri, Fabio Stagno, MD, Gianantonio Rosti, MD, Michele Baccarani, MD
Journal: Blood
Blood (2016) 128 (22): 3076.
https://doi.org/10.1182/blood.V128.22.3076.3076
Published: 2016
Journal Articles

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Paolo Vigneri, MDPhD, Fabio Stagno, MDPhD, Stefania Stella, PhD, Alessandra Cupri, MD, Stefano Forte, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Clementina Caracciolo, MD, Laura Nocilli, MD, Stefana Impera, MD, Caterina Musolino, Diamante Turri, MD, Mario Russo, MD, Carmela Anna Maria Tomaselli, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, MD, Livia Manzella, MDPhD, Martin C Mueller, MD, Andreas Hochhaus, MD, Francesco Di Raimondo, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4049.
https://doi.org/10.1182/blood.V126.23.4049.4049
Published: 2015